Pharma Journalist - Page 852 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

ViraCyte Announces Positive Phase 2 Trial Results

Ethris, AstraZeneca & MedImmune to develop mRNA Therapies for Respiratory Diseases

Pfizer Receives U.S. FDA Approval for BESPONSA (inotuzumab ozogamicin)

Champions Oncology to collaborate with ALCMI to develop unique cohort of PDX models

Medivir Licenses Exclusive Rights to MIV-802 for Greater China to Ascletis

Samsung Bioepis and Takeda Sign Strategic Collaboration Agreement

Teva Announces Exclusive Launch of Generic Axiron in the United States

Hikma announces new licensing agreement with Takeda

Valeant Receives FDA Confirmation Of VAI Inspection Classification For Tampa Facility

Johnson & Johnson Announces Partnership with CSIR-IMTECH to Develop Innovative New Tuberculosis Treatments